CHICAGO (August 8, 2017) — Gateway for Cancer Research founder Richard J Stephenson and Dr. Stacie
J. Stephenson announce the annual Cures Gala, “Gateway to OZ,” on November 18, 2017 at the Grand
Ballroom at McCormick Place, 2301 South King Drive, Chicago. The Emerald City-worthy event, co-
chaired and presenting sponsors Richard J Stephenson and Dr. Stacie J. Stephenson and honorary chair
Jim Gordon, Founder & Managing Partner of The Edgewater Funds, will celebrate the “courage,
intelligence and heart” of Gateway, a non-profit dedicated to funding transformational cancer research.
Click your heels along a magical journey beginning with a unique culinary experience followed by a
special presentation of world renowned entertainment. Tickets are $1,000 per person. For sponsorship
opportunities, contact email@example.com.
All proceeds from “Gateway to OZ” will help support Gateway for Cancer Research Phase I and Phase II
trials across cancer types, including breast, blood and lung cancers.
Gateway’s Associates Board, consisting of young professionals in the Chicago area, will host its annual
Be A Hero Cocktail Reception on Friday, November 17, to kick-off the weekend’s celebration.
To purchase 2017 “Gateway to OZ” and Be a Hero Cocktail Reception tickets contact
For more information about Gateway for Cancer Research and the clinical research trials it funds, visit
www.GatewayCR.org and follow the conversation online at #DemandCures.
ABOUT GATEWAY FOR CANCER RESEARCH
“Our mission instills a sense of urgency to accelerate the pace of cancer research,” said Teresa Hall
Bartels, president, Gateway for Cancer Research. “Our dedication to investing in novel patient-centric
approaches, combined with the increasing rate of treatment advances, leads us to believe that together
we can conquer cancer in our lifetime.”
Gateway for Cancer Research℠ is a nonprofit 501(c)(3) organization committed to funding innovative
cancer research that helps people living with cancer to feel better, live longer and conquer cancer
TODAY! Thanks to generous underwriting, 99 cents of every dollar Gateway receives directly funds
Phase I and Phase II cancer clinical trials at leading research institutions across the country and abroad.
Since 1991, Gateway has supported more than 150 clinical trials and funded over $70 million in
breakthrough cancer research. Get involved today by visiting www.GatewayCR.org, like us on Facebook
at facebook.com/demandcures and join the conversation on Twitter at @DemandCures, #BeAGateway.